Executive Leadership Team

Our day-to-day activities are managed by the Executive team, which is made up of senior managers from across the organisation. 

Portrait of Jeremy Farrar

Jeremy Farrar

Director of the Wellcome Trust

Before joining Wellcome in October 2013, Jeremy was Director of the Oxford University Clinical Research Unit in Vietnam, where his research interests were infectious diseases, tropical health and emerging infections. He has contributed to 500 peer-reviewed scientific papers and has served on several World Health Organization advisory committees.

Jeremy was appointed OBE in 2005 for services to tropical medicine, and he has been awarded the Memorial Medal and the Ho Chi Minh City Medal by the Government of Vietnam, the Frederick Murgatroyd Prize for Tropical Medicine by the Royal College Physicians and the Bailey Ashford Award by the American Society for Tropical Medicine and Hygiene. He is a Fellow of the Academy of Medical Sciences.

Jeremy is married with three children. He loves all sport and walking in the Alps.

Chris Bird

Chris Bird

Head of Legal

Chris leads our Legal team and is the senior legal adviser and company secretary to Wellcome and its subsidiaries. During his time at Wellcome, Chris has been involved in and led some of our highest profile projects and policy interests.

Before joining Wellcome in 2000, Chris was an Associate Solicitor with Osborne Clarke LLP. A legal firm based in the City of London, Thames Valley and Bristol, it has a significant presence throughout Europe and West Coast USA.

Portrait of Wellcome Executive Board member Steve Caddick

Stephen Caddick

Director of Innovations

Stephen joined Wellcome in June 2015. Previously, he was Vice Provost (Enterprise & London) and Vernon Professor of Organic Chemistry and Chemical Biology at University College London.

He is co-founder of Synthetic Pages, an open access website, and Thiologics, an antibody-drug conjugate (ADC) biotech spinout company. His laboratory focuses on chemical modification of proteins and antibodies for development of therapeutics and diagnostics.

He has played an important role in the development of the chemical biology strategy and facilities within the Francis Crick Institute.

Portrait of Wellcome Executive Board member Simon Chaplin

Simon Chaplin

Director of Culture & Society

Simon joined Wellcome in February 2010. Before taking up his current role in November 2014, he was head of the Wellcome Library, where he led a highly successful digitisation programme and an exciting redesign of the library's public spaces.

Simon originally studied zoology, before an interest in the history of science and medicine led him to join the Science Museum, where he worked on the Wellcome medical collections and managed the PRISM Grant Fund for preservation of industrial and scientific material.

Before joining Wellcome, Simon was Director of Museums and Special Collections at the Royal College of Surgeons, where he led the curatorial team responsible for the redevelopment of the Hunterian Museum.

His academic research interests include the history of anatomy and medical museums.

Alyson Fox

Alyson Fox

Head of Grants Management

Alyson joined Wellcome in November 2010. She has responsibility for the management and governance of our grant funding and review processes.

Before Wellcome, she pursued a research career, at University College London and Imperial College, and then in the pharma industry. Alyson spent 13 years working in drug discovery at Novartis, ultimately leading a therapeutic area responsible for a portfolio of projects from target discovery and preclinical development to clinical trials.

She has experience in neuroscience, respiratory and gastrointestinal research areas.

Peter Gray

Peter Pereira Gray

Joint Managing Partner of Investments

Peter joined Wellcome in January 2001. He works with a team managing Wellcome's £20 billion multi-asset global investment portfolio. Peter's day-to-day responsibilities include overseeing Wellcome's privately held assets (private equity, real estate, venture capital and private direct holdings). In addition, he is Chair of the farming and land management business, FarmCare Ltd, and of Premier Marinas Ltd. Peter is also a Main Board Director of Vero Group Limited, the newly formed student housing joint venture with Goldman Sachs.

He is a life member and past Chair of the Investment Property Forum, a past founding and advisory board member and member of the management board of INREV, a member of the Bank of England Commercial and Residential Property Forums, and a Fellow of the Royal Institution of Chartered Surveyors.

Peter is also an Advisory Board member for Composition Capital Partners, an honorary vice-president of Cambridge University Land Society, a Life Fellow of the Royal Society of Arts, and an Advisory Board member and Honorary Fellow of the Institute of Continuing Professional Development.

Mark Henderson, Head of Communications

Mark Henderson

Head of Communications

Mark leads all aspects of our communications, with a particular focus on building and sustaining Wellcome's reputation and influence so that our work contributes more to health and society. His team's responsibilities include brand, media relations, digital products, content, campaigns, design and understanding our audiences. 

Mark joined Wellcome in 2012. Before that, he had a 15-year career in journalism at The Times of London, where he was Science Editor and won several awards for his reporting.

He has written two books: 'The Geek Manifesto: Why Science Matters', which explores the relationship between science and politics, and '50 Genetics Ideas You Really Need to Know'. He is an avid skier.

Chonnettia Jones

Chonnettia Jones

Head of Insight and Analysis

Chonnettia joined Wellcome in 2012. She has responsibility for assessing the performance and impact of our funded research and activities. Before taking up this role in January 2016, she headed the science integration team, which managed the coordination, monitoring and assessment of major science funding initiatives. 

Before Wellcome, Chonnettia studied developmental neurobiology as a Ruth L. Kirschstein research fellow at Emory University. She went on to lecture at American universities before managing a collaborative scientific research programme at the Janelia Research Campus of the Howard Hughes Medical Institute. 

Chonnettia is an active mentor, and has acquired a new interest in history and architecture since moving to London to complement her love of travel.

Portrait of Wellcome Executive Board member Tim Livett

Tim Livett

Chief Financial Officer

Tim joined Wellcome in December 2014 and is responsible for the leadership of the Finance and IT departments.

After graduating in chemistry, he joined ICI/Zeneca and trained as an accountant. He has spent the majority of his career in commercial aviation, working for British Airways and, after a short break, at Virgin Atlantic, most recently in the role of Chief Financial Officer.

Nick Moakes, Wellcome's joint managing partner of Investments

Nick Moakes

Joint Managing Partner of Investments

Nick is directly responsible for Wellcome's global equity, FX and derivatives exposure, as well as playing a key role in broader investment strategy and management of the Investment Team. He is a member of our Investment Committee.

Nick joined Wellcome in 2007 from BlackRock Investment Management where he was Head of the Asia Pacific investment team and co-head of Emerging Markets. He has 27 years' professional experience in Asia, and 22 years' experience in global equity markets.

He graduated in Modern History and Economics from Balliol College, Oxford, and is a CFA charter holder.  Before joining BlackRock in 1997, Nick lived in Hong Kong for nine years. He is a Chinese speaker. He started his career in the Diplomatic Service.

Nick is Chair of the Imperial College London Endowment Fund and a Non-Executive Director of the Foreign and Colonial Investment Trust. He's also a Board Member of the UK Investor Forum, which aims to align the interests of listed companies and long-term shareholders.

Jim Smith, Wellcome's head of science

Jim Smith

Director of Science

Jim joined Wellcome's leadership team on 1 December 2016. He's responsible for leading the Science Division, developing Wellcome's science research strategy and managing a broad research portfolio.

A globally recognised developmental biologist, Jim's research interests include inductive interactions in vertebrate development and applying the principles of developmental biology to stem cell differentiation. He has a distinguished career in scientific research as a Fellow of the Royal Society (1993), a Fellow of the Academy of Medical Sciences (1998) and a member of the Academia Europaea (2000). He has also been awarded the EMBO Medal (1993) and the Waddington Medal (2013).  

Jim's previous roles include Director of the Wellcome Trust/Cancer Research UK Gurdon Institute and Director of the MRC National Institute for Medical Research (NIMR), where he oversaw its transition to the Francis Crick Institute. More recently he has been Deputy CEO and Chief of Strategy at the Medical Research Council, and Director of Research and Group Leader at the Francis Crick Institute. He will continue to hold the position of Senior Group Leader and run his lab at the Francis Crick Institute. 

Portrait of Wellcome Executive Board member Ted Smith

Ted Smith

Director of People & Facilities

Ted joined Wellcome at the beginning of 2015. He has responsibility for buildings, travel, health and safety, meetings, catering and cleaning services, internal communications, and human resources.

For the previous five years, Ted had worked as Group HR Director of the Medical Research Council.

He has also worked at Glaxo Group Research, GlaxoWellcome and GSK (where his last role was as Vice President HR), at two market research companies, and at Vernalis, a Cambridge-based biotech company. Ted has also held trustee roles at two charities, Wysing Arts and Herts Careers Service.

He has a degree in Science and the Environment, and a love of live music, photography and sport.

James Thomas

James Thomas

Chief Technology Officer

James joined Wellcome in April 2016. He is responsible for leadership of our technology and digital services. 

Before Wellcome, James had an extensive career in the private and public sectors, delivering transformational change through technology and data.

His career began in the oil and water industries, with BP and Veolia. He moved to global technology provider Oracle to develop and lead technology consulting services for clients, including banking, defence and manufacturing. 

He then moved into healthcare, with technology leadership roles in the NHS. This included eight years as a Director of UCL Hospitals, establishing UCL Partners, London NHS Procurement Partnership and the UCH Macmillan Cancer Centre. Following this, James became an Associate Partner at Atos Consulting, including working with Genomics England to review its Informatics and bioinformatics capabilities.

Portrait of Wellcome Executive Board member Danny Truell

Danny Truell

Joint Managing Partner of Investments

Danny joined Wellcome in 2005, having previously been a Managing Director of Goldman Sachs in its investment management division. Before joining Goldman Sachs in 1996, Danny's career was focused on Asian financial markets.

Ed Whiting

Ed Whiting

Director of Policy and Chief of Staff

Ed joined Wellcome in September 2016. He has worked in a number of Whitehall social and financial policy departments during his civil service career, including HM Treasury's financial stability team during the 2008-09 financial crisis. He was most recently at 10 Downing Street as Deputy Principal Private Secretary to the Prime Minister, leading on public services.

In addition to his civil service career, in 2011-12 Ed set up and ran a small arts crowdfunding website. In 2012-13 he was an elected member of the RSA's Fellowship Council.

Ed was awarded an OBE for public service and services to 10 Downing Street in the June 2016 Queen's Birthday Honours list.